Farmaforum Partnering Day 2025

18 Sept 2025 | Madrid, Spain

Register
Register
Register

ProductUpdated on 28 June 2025

ThymoTropin™ – Natural Myostatin-Regulating Ingredient for Muscle Health

Bassam Damaj

President & CEO at Veos Pharmaceuticals, SL

Madrid, Madrid, Spain

About

ThymoTropin™ is a patented, clinically validated functional ingredient designed to help preserve muscle strength, mobility, and endurance. In a human trial, it reduced serum myostatin levels by 36.2% in 60 days, with reported improvements in physical performance, mood, and recovery.

ThymoTropin™ is approved and commercially available in Canada as a Natural Health Product (NHP). Its core components are listed in EFSA’s food supplement database and recognized as GRAS by the U.S. FDA, supporting its regulatory readiness in global markets.

It is ideal for formulation into FFC-compliant supplements, beverages, or capsules targeting sarcopenia, pre-frailty, or active aging.

Looking for

  • Distribution Partner

Applies to

  • Pharmaceutical industry
  • Health innovation

Similar opportunities

  • Product

    Life Science and Pharmaceuticals

    • Other
    • Importer
    • Publisher
    • Digital health
    • Cosmetic industry
    • Health innovation
    • Distribution Partner
    • Laboratory industry
    • Pharmaceutical industry

    Marcus Freitas Ernst

    CEO Softexpert EMEA at Softexpert

    Madrid, Spain

  • Service

    Physiotherapy

    Raquel Rodriguez

    Technology Transfer and Innovation Promotion Specialist at Universidad de Alcalá

    Alcalá de Henares, Spain

  • Service

    Bioanalytical Services

    • Development
    • Laboratory industry
    • Pharmaceutical industry

    Kseniya Tymko

    Business Development Director at Pharmbiotest Poland Ltd

    Grudziadz, Poland